搜尋結果
2022
Lin, H. Y. ,
Yang, Y. N. ,
Chen, Y. F. ,
Huang, T. Y. ,
Crawford, D. R. ,
Chuang, H. Y. ,
Chin, Y. T. ,
Chu, H. R. ,
Li, Z. L. ,
Shih, Y. J. ,
Chen, Y. R. ,
Yang, Y. C. S. H. ,
Ho, Y. ,
Davis, P. J. ,
Whang-Peng, J. &
Wang, K. ,
8月 30 2022 ,
於: Frontiers in Cell and Developmental Biology. 10 , 862045.
研究成果: 雜誌貢獻 › 文章 › 同行評審
2,3,5,4'-tetrahydroxystilbene 2-O-glucopyranoside
100%
Oocytes
20%
Aromatase
10%
Infertility
8%
Ovary
7%
Su, K. W. ,
Lin, H. Y. ,
Chiu, H. C. ,
Shen, S. Y. ,
Chang, O-C. ,
Crawford, D. R. ,
Yang, Y-C. ,
Shih, Y. J. ,
Li, Z. L. ,
Huang, H. M. ,
Whang-Peng, J. ,
Ho, Y. &
Wang, K. ,
10月 2022 ,
於: Cells. 11 ,
19 , 3050.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Thyroid Hormone
100%
Mouth Neoplasms
80%
Thyroid Hormones
74%
Ligands
52%
Growth
37%
2021
Lin, H. C. ,
Chen, Y. Y. ,
Lin, H. L. ,
Uang, Y. S. ,
Ho, Y. &
Wang, L. H. ,
2021 ,
於: Journal of Clinical Pharmacy and Therapeutics. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Gastrointestinal Diseases
100%
Atopic Dermatitis
98%
Acids
70%
Cohort Studies
64%
Retrospective Studies
63%
Lin, S. J. ,
Tai, L. ,
Huang, Y. J. ,
Uang, Y. S. ,
Ho, Y. ,
Hsu, K. Y. &
Wang, L. H. ,
2021 , (接受/付印)
於: Biomedical Chromatography. 研究成果: 雜誌貢獻 › 文章 › 同行評審
L-Dopa
100%
Dihydroxyphenylalanine
87%
Catechin
85%
Levodopa
75%
Tea
74%
Chen, S-H. ,
Wang, Y-R. ,
Ho, Y. ,
Lin, S-J. &
Liu, H. L. ,
12月 2021 ,
於: Journal of Biomedical Science and Engineering. 14 ,
12 ,
p. 371-390 12.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Solvation
100%
Proliferative
78%
Free Energy of Binding
73%
Van Der Waals Force
59%
Bioassay
56%
Chang, S. F. ,
Liu, H. L. ,
Ho, Y. ,
Yang, L. M. ,
Tsai, Y. E. ,
Chou, B. H. ,
Wang, S. H. &
Lin, S. J. ,
7月 2021 ,
於: Phytochemistry. 187 , 112776.
研究成果: 雜誌貢獻 › 文章 › 同行評審
steviol
100%
Mortierella
97%
Cunninghamella
90%
Aspergillus niger
70%
Dexamethasone
66%
Lin, H. C. ,
Huang, K. T. ,
Lin, H. L. ,
Uang, Y. S. ,
Ho, Y. ,
Keller, J. J. &
Wang, L. H. ,
3月 2021 ,
於: PLoS ONE. 16 ,
3 ,
p. e0249050 e0249050.
研究成果: 雜誌貢獻 › 文章 › 同行評審
proton pump inhibitors
100%
Proton Pump Inhibitor
93%
dementia
86%
cohort studies
83%
gastric acid
83%
2020
Lin, H. C. ,
Hsu, H. Y. ,
Lin, H. L. ,
Uang, Y. S. ,
Ho, Y. &
Wang, L. H. ,
1月 1 2020 ,
於: Dose-Response. 18 ,
2 研究成果: 雜誌貢獻 › 文章 › 同行評審
Gastrointestinal Diseases
100%
Acids
95%
Hepatocellular Carcinoma
85%
Dose
80%
Hazards
41%
Ho, Y. ,
Zi-Lin, L. ,
Ya-Jung, S. ,
Yi-Ru, C. ,
Wang, K. ,
Whang-Peng, J. ,
Hung-Yun, L. &
Davis, P. J. ,
4月 21 2020 ,
於: International Journal of Molecular Sciences. 21 ,
8 , 2906.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Resveratrol
100%
Cell proliferation
73%
Hormones
72%
breast
52%
Integrins
47%
Ho, Y. ,
Wu, C. Y. ,
Chin, Y. T. ,
Li, Z. L. ,
Pan, Y. S. ,
Huang, T. Y. ,
Su, P. Y. ,
Lee, S. Y. ,
Crawford, D. R. ,
Su, K. W. ,
Chiu, H. C. ,
Shih, Y. J. ,
Changou, C. A. ,
Yang, Y. C. S. H. ,
Whang-Peng, J. ,
Chen, Y. R. ,
Lin, H. Y. ,
Mousa, S. A. ,
Davis, P. J. &
Wang, K. ,
2月 1 2020 ,
於: Food and Chemical Toxicology. 136 ,
p. 111092 111092.
研究成果: 雜誌貢獻 › 文章 › 同行評審
nano-diamino-tetrac
100%
Resveratrol
54%
resveratrol
52%
Mouth Neoplasms
47%
neoplasm cells
39%
2019
Ho, Y. ,
Wang, S. H. ,
Chen, Y. R. ,
Li, Z. L. ,
Chin, Y. T. ,
Yang, Y. C. S. H. ,
Wu, Y. H. ,
Su, K. W. ,
Chu, H. R. ,
Chiu, H. C. ,
Crawford, D. R. ,
Shih, Y. J. ,
Grasso, P. ,
Tang, H. Y. ,
Lin, H. Y. ,
Davis, P. J. ,
Whang-Peng, J. &
Wang, K. ,
11月 1 2019 ,
於: Food and Chemical Toxicology. 133 ,
p. 110808 110808.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Leptin
100%
leptin
67%
hepatoma
64%
leptin (116-130)
62%
Hepatocellular Carcinoma
47%
Chin, Y-T. ,
He, Z-R. ,
Chen, C-L. ,
Chu, H-C. ,
Ho, Y. ,
Su, P-Y. ,
Yang, Y-C. S. H. ,
Wang, K. ,
Shih, Y-J. ,
Chen, Y-R. ,
Pedersen, J. Z. ,
Incerpi, S. ,
Nana, A. W. ,
Tang, H-Y. ,
Lin, H-Y. ,
Mousa, S. A. ,
Davis, P. J. &
Whang-Peng, J. ,
1月 1 2019 ,
於: Frontiers in Endocrinology. 10 ,
APR ,
p. 130 130.
研究成果: 雜誌貢獻 › 文章 › 同行評審
tetraiodothyroacetic acid
100%
Integrins
54%
Colorectal Neoplasms
45%
HCT116 Cells
12%
HT29 Cells
11%
2018
Lin, H. Y. ,
Tey, S. L. ,
Ho, Y. ,
Chin, Y. T. ,
Wang, K. ,
Whang-Peng, J. ,
Shih, Y. J. ,
Chen, Y. R. ,
Yang, Y. N. ,
Chen, Y. C. ,
Liu, Y. C. ,
Tang, H. Y. &
Yang, Y. C. SH. ,
12月 6 2018 ,
於: Marine Drugs. 16 ,
12 , 489.
研究成果: 雜誌貢獻 › 文章 › 同行評審
heteronemin
100%
Cholangiocarcinoma
52%
Signal Transduction
48%
Transforming Growth Factors
47%
Antitumor
41%
Ho, Y. ,
Chen, Y. F. ,
Wang, L. H. ,
Hsu, K. Y. ,
Chin, Y. T. ,
Yang, Y. C. S. H. ,
Wang, S. H. ,
Chen, Y. R. ,
Shih, Y. J. ,
Liu, L. F. ,
Wang, K. ,
Whang-Peng, J. ,
Tang, H. Y. ,
Lin, H. Y. ,
Liu, H. L. &
Lin, S. J. ,
8月 2 2018 ,
於: Frontiers in Pharmacology. 9 ,
AUG ,
p. 807 807.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Obese Mice
100%
Hyperglycemia
99%
Blood Glucose
67%
Metformin
58%
Hypoglycemic Agents
51%
Nana, A. W. ,
Wu, S. Y. ,
Yang, Y. C. S. ,
Chin, Y. T. ,
Cheng, T. M. ,
Ho, Y. ,
Li, W. S. ,
Liao, Y. M. ,
Chen, Y. R. ,
Shih, Y. J. ,
Liu, Y. R. ,
Pedersen, J. ,
Incerpi, S. ,
Hercbergs, A. ,
Liu, L. F. ,
Whang-Peng, J. ,
Davis, P. J. &
Lin, H. Y. ,
10月 1 2018 ,
於: Hormones and Cancer. 9 ,
5 ,
p. 349-360 12 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
nano-diamino-tetrac
100%
Resveratrol
50%
Oxidoreductases
39%
Colorectal Neoplasms
34%
Stilbenes
26%
Lin, S. J. ,
Chin, Y. T. ,
Ho, Y. ,
Chou, S. Y. ,
Sh Yang, Y. C. ,
Nana, A. W. ,
Su, K. W. ,
Lim, Y. T. ,
Wang, K. ,
Lee, SY. Y. ,
Shih, Y. J. ,
Chen, Y. R. ,
Whang-Peng, J. ,
Davis, P. J. ,
Lin, H. Y. &
Fu, E. ,
10月 1 2018 ,
於: Food and Chemical Toxicology. 120 ,
p. 1-11 11 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
nano-diamino-tetrac
100%
Mouth Neoplasms
47%
neoplasm cells
39%
ligands
39%
death
33%
Cheng, T. M. ,
Chin, Y. T. ,
Ho, Y. ,
Chen, Y. R. ,
Yang, Y. N. ,
Yang, Y. C. ,
Shih, Y. J. ,
Lin, T. I. ,
Lin, H. Y. &
Davis, P. J. ,
2月 1 2018 ,
於: Food and Chemical Toxicology. 112 ,
p. 67-75 9 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
prostatic neoplasms
100%
Resveratrol
92%
resveratrol
88%
prostaglandin synthase
81%
Cyclooxygenase 2
76%
Ho, Y. ,
SH Yang, Y. C. ,
Chin, Y. T. ,
Chou, S. Y. ,
Chen, Y. R. ,
Shih, Y. J. ,
Whang-Peng, J. ,
Changou, C. A. ,
Liu, H. L. ,
Lin, S. J. ,
Tang, H. Y. ,
Lin, H. Y. &
Davis, P. J. ,
10月 1 2018 ,
於: Food and Chemical Toxicology. 120 ,
p. 346-355 10 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Resveratrol
100%
integrins
99%
resveratrol
95%
somatomedins
91%
Myoma
89%
Nana, A. W. ,
Chin, Y. T. ,
Lin, C. Y. ,
Ho, Y. ,
Bennett, J. A. ,
Shih, Y. J. ,
Chen, Y. R. ,
Changou, C. A. ,
Pedersen, J. Z. ,
Incerpi, S. ,
Liu, L. F. ,
Whang-Peng, J. ,
Fu, E. ,
Li, W. S. ,
Mousa, S. A. ,
Lin, H. Y. &
Davis, P. J. ,
3月 1 2018 ,
於: Endocrine-Related Cancer. 25 ,
3 ,
p. 279-293 15 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
tetraiodothyroacetic acid
100%
High Mobility Group Proteins
82%
Catenins
72%
Resveratrol
67%
varespladib methyl
60%
Chin, Y. T. ,
Wei, P. L. ,
Ho, Y. ,
Nana, A. W. ,
Changou, C. A. ,
Chen, Y. R. ,
Yang, Y. C. SH. ,
Hsieh, M. T. ,
Hercbergs, A. ,
Davis, P. J. ,
Shih, Y. J. &
Lin, H. Y. ,
5月 1 2018 ,
於: Endocrine-Related Cancer. 25 ,
5 ,
p. 533-545 13 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Resveratrol
100%
Cyclooxygenase 2
89%
Thyroxine
87%
Ovarian Neoplasms
77%
Ligands
60%
2017
Lin, H. C. ,
Daimon, M. ,
Wang, C. H. ,
Ho, Y. ,
Uang, Y. S. ,
Chiang, S. J. &
Wang, L. H. ,
4月 15 2017 ,
於: International Journal of Cardiology. 233 ,
p. 85-90 6 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
benzbromarone drug combination allopurinol
100%
Gout
61%
Coronary Disease
45%
Coronary Artery Disease
42%
Benzbromarone
24%
2015
Zhou, Z. L. ,
Ho, Y. ,
Liu, H. L. ,
Elumalai, P. &
Chen, W. H. ,
5月 24 2015 ,
於: Molecular Simulation. 41 ,
8 ,
p. 622-632 11 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Amyloid
100%
Peptides
83%
Alzheimer's Disease
82%
Inhibitor
74%
inhibitors
68%
Wang, J. L. ,
Liu, H. L. ,
Zhou, Z. L. ,
Chen, W. H. &
Ho, Y. ,
3月 4 2015 ,
於: Molecular Simulation. 41 ,
4 ,
p. 287-297 11 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Virtual Screening
100%
Molecular Docking
96%
Molecular Dynamics Simulation
78%
Oxidoreductases
77%
Inhibitor
64%
2014
Zhou, Z. L. ,
Liu, H. L. ,
Wu, J. W. ,
Tsao, C. W. ,
Chen, W. H. ,
Liu, K. T. &
Ho, Y. ,
1月 2014 ,
於: Letters in Drug Design and Discovery. 11 ,
3 ,
p. 339-348 10 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Tafamidis
100%
Amyloidosis, Hereditary, Transthyretin-Related
76%
Prealbumin
60%
tafamidis
60%
Chemical Databases
49%
Zhou, Z. L. ,
Liu, H. L. ,
Wu, J. W. ,
Tsao, C. W. ,
Chen, W. H. ,
Liu, K. T. &
Ho, Y. ,
2014 ,
於: Journal of the Chinese Chemical Society. 61 ,
2 ,
p. 263-273 11 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Tafamidis
100%
Molecular Dynamics
35%
Simulation
30%
Halogen
21%
Binding Energy
21%
Liao, H. S. ,
Liu, H. L. ,
Chen, W. H. &
Ho, Y. ,
8月 2014 ,
於: Medicinal Chemistry Research. 23 ,
8 ,
p. 3725-3732 8 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
anthrax toxin
100%
Hydrogen Bonding
81%
Lethal
81%
N-(2(R)-2-(hydroxamidocarbonylmethyl)-4-methylpentanoyl)-L-tryptophan methylamide
54%
Anthrax
46%
2013
Zhou, Z. L. ,
Liu, H. L. ,
Wu, J. W. ,
Tsao, C. W. ,
Chen, W. H. ,
Liu, K. T. &
Ho, Y. ,
12月 2013 ,
於: Chemical Biology and Drug Design. 82 ,
6 ,
p. 705-717 13 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Serotonin
100%
Serotonin Uptake Inhibitors
99%
Computer Simulation
85%
Serotonin Plasma Membrane Transport Proteins
56%
National Cancer Institute (U.S.)
52%
Lin, Y. S. ,
Ho, Y. ,
Hu, C. J. ,
Su, W. W. ,
Hsu, K. Y. ,
Shen, W. W. ,
Chiueh, C. C. &
Yuan, R. Y. ,
4月 2013 ,
於: Journal of Experimental and Clinical Medicine(Taiwan). 5 ,
2 ,
p. 77-80 4 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Medication Adherence
100%
Taiwan
89%
Expert Testimony
26%
Neurology
13%
Patient Compliance
12%
2012
Elumalai, P. ,
Liu, H. L. ,
Zhou, Z. L. ,
Zhao, J. H. ,
Chen, W. ,
Chuang, C. K. ,
Tsai, W. B. &
Ho, Y. ,
1月 2012 ,
於: Letters in Drug Design and Discovery. 9 ,
1 ,
p. 17-29 13 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Histamine N-Methyltransferase
100%
Histamine
65%
Ligands
41%
Ligand
25%
Vasoconstriction
14%
Elumalai, P. ,
Liu, H. L. ,
Zhao, J. H. ,
Chen, W. ,
Lin, D. S. ,
Chuang, C. K. ,
Tsai, W. B. &
Ho, Y. ,
7月 2012 ,
於: Journal of the Taiwan Institute of Chemical Engineers. 43 ,
4 ,
p. 493-503 11 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Hydrogen bonds
100%
Histamine
82%
Screening
67%
Neurodegenerative diseases
54%
Mammals
50%
Liao, H. S. ,
Wu, J. W. ,
Liu, H. L. ,
Zhao, J. H. ,
Tsao, C. W. ,
Liu, K. T. ,
Chuang, C. K. ,
Lin, H. Y. ,
Tsai, W. B. &
Ho, Y. ,
11月 2012 ,
於: Journal of the Chinese Chemical Society. 59 ,
11 ,
p. 1430-1438 9 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Antiviral Agent
100%
Hydrogen Bond
94%
Bioactivity
55%
Acid
26%
Application
24%
2011
Lin, Y. F. ,
Zhao, J. H. ,
Liu, H. L. ,
Wu, J. W. ,
Chuang, C. K. ,
Liu, K. T. ,
Lin, H. Y. ,
Tsai, W. B. &
Ho, Y. ,
5月 2011 ,
於: Journal of the Taiwan Institute of Chemical Engineers. 42 ,
3 ,
p. 394-401 8 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Insulin (Human)
100%
Insulin
93%
Peptides
91%
Agglomeration
59%
Oligomers
42%
Lu, S. H. ,
Wu, J. W. ,
Liu, H. L. ,
Zhao, J. H. ,
Liu, K. T. ,
Chuang, C. K. ,
Lin, H. Y. ,
Tsai, W. B. &
Ho, Y. ,
2011 ,
於: Journal of Biomedical Science. 18 ,
1 , 8.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Cholinergic
100%
Cholinesterase Inhibitor
95%
Cholinesterase Inhibitors
90%
Acetylcholinesterase
87%
Cholinergic Agents
29%
Zhou, Z. L. ,
Zhao, J. H. ,
Liu, H. L. ,
Wu, J. W. ,
Liu, K. T. ,
Chuang, C. K. ,
Tsai, W. B. &
Ho, Y. ,
4月 2011 ,
於: Journal of Biomolecular Structure and Dynamics. 28 ,
5 ,
p. 743-758 16 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
polyglutamine
100%
Structural Models
89%
Molecular Dynamics Simulation
84%
Huntington Disease
14%
Glutamine
13%
2010
Zhao, J. H. ,
Liu, H. L. ,
Chuang, C. K. ,
Liu, K. T. ,
Tsai, W. B. &
Ho, Y. ,
11月 2010 ,
於: Molecular Simulation. 36 ,
13 ,
p. 1013-1024 12 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Amyloid
100%
Molecular Dynamics Simulation
90%
Oligomers
84%
Peptides
83%
oligomers
68%
Lin, Y. F. ,
Zhao, J. H. ,
Liu, H. L. ,
Liu, K. T. ,
Chen, J. T. ,
Tsai, W. B. &
Ho, Y. ,
2010 ,
於: Biopolymers. 94 ,
3 ,
p. 269-278 10 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Insulin (Human)
100%
Insulin
93%
Peptides
91%
Molecular dynamics
77%
Molecular Dynamics Simulation
77%
Chang, L. K. ,
Zhao, J. H. ,
Liu, H. L. ,
Wu, J. W. ,
Chuang, C. K. ,
Liu, K. T. ,
Chen, J. T. ,
Tsai, W. B. &
Ho, Y. ,
8月 2010 ,
於: Journal of Biomolecular Structure and Dynamics. 28 ,
1 ,
p. 39-50 12 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Amyloid
100%
Peptides
67%
polypeptide C
38%
Prion Diseases
32%
Molecular Dynamics Simulation
29%
2009
Lai, Y. C. ,
Ho, Y. ,
Huang, K. H. &
Tsai, L-H. ,
2009 ,
於: Chinese Journal of Physiology. 52 ,
SUPPL. 5 ,
p. 395-405 11 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Receptors, Serotonin, 5-HT3
100%
Serotonin
64%
Acids
57%
Stomach
54%
Oxotremorine
25%
Chang, S. F. ,
Chou, B. H. ,
Yang, L. M. ,
Hsu, F. L. ,
Lin, W. K. ,
Ho, Y. &
Lin, S. J. ,
9月 1 2009 ,
於: Bioorganic and Medicinal Chemistry. 17 ,
17 ,
p. 6348-6353 6 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
isosteviol
100%
Oximes
69%
Transcription Factor AP-1
55%
Oxime
49%
Acids
38%
Zhao, J. H. ,
Liu, H. L. ,
Liu, Y. F. ,
Lin, H. Y. ,
Fang, H. W. ,
Ho, Y. &
Tsai, W. B. ,
2月 2009 ,
於: Journal of Biomolecular Structure and Dynamics. 26 ,
4 ,
p. 481-490 10 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Molecular Dynamics Simulation
100%
Amyloid
85%
Alzheimer Disease
69%
A 17
67%
Hydrophobic and Hydrophilic Interactions
49%
Fang, P. S. ,
Zhao, J. H. ,
Liu, H. L. ,
Liu, K. T. ,
Chen, J. T. ,
Tsai, W. B. ,
Lin, H. Y. ,
Fang, H. W. &
Ho, Y. ,
8月 2009 ,
於: Molecular Simulation. 35 ,
9 ,
p. 755-765 11 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Amyloid
100%
Molecular Dynamics Simulation
90%
deletion
82%
Structural Stability
73%
structural stability
68%
Chang, L. K. ,
Zhao, J. H. ,
Liu, H. L. ,
Liu, K. T. ,
Chen, J. T. ,
Tsai, W. B. &
Ho, Y. ,
6月 2009 ,
於: Journal of Biomolecular Structure and Dynamics. 26 ,
6 ,
p. 731-740 10 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Molecular Dynamics Simulation
100%
Amyloid
85%
Peptides
57%
Wolfiporia
36%
Structural Models
26%
2008
Zhao, J. H. ,
Yang, C. T. ,
Wu, J. W. ,
Tsai, W. B. ,
Lin, H. Y. ,
Fang, H. W. ,
Ho, Y. &
Liu, H. L. ,
8月 2008 ,
於: Journal of Biomolecular Structure and Dynamics. 26 ,
1 ,
p. 65-73 9 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Ubiquitin-Protein Ligases
100%
Molecular Dynamics Simulation
97%
Zinc
28%
Ions
24%
Hydrogen Bonding
17%
2007
Liu, H. L. ,
Wu, Y. C. ,
Zhao, J. H. ,
Liu, Y. F. ,
Huang, C. H. ,
Fang, H. W. &
Ho, Y. ,
1月 2007 ,
於: Biotechnology Progress. 23 ,
1 ,
p. 246-254 9 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Familial Amyloidosis
100%
amyloidosis
91%
Muramidase
73%
lysozyme
63%
center of gravity
42%
Liu, H. L. ,
Lin, Y. M. ,
Zhao, J. H. ,
Hsieh, M. C. ,
Lin, H. Y. ,
Huang, C. H. ,
Fang, H. W. ,
Ho, Y. &
Chen, W. Y. ,
10月 2007 ,
於: Journal of Biomolecular Structure and Dynamics. 25 ,
2 ,
p. 135-144 10 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
L68Q cystatin C
100%
Molecular Dynamics Simulation
51%
Amyloid angiopathy
35%
Temperature
33%
Cystatin C
29%
Lin, Y. M. ,
Liu, H. L. ,
Zhao, J. H. ,
Huang, C. H. ,
Fang, H. W. ,
Ho, Y. &
Chen, W. Y. ,
5月 2007 ,
於: Biotechnology Progress. 23 ,
3 ,
p. 577-584 8 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Cystatin C
100%
Molecular Dynamics Simulation
87%
Temperature
24%
Viperidae
15%
Amyloid Plaques
12%
Liu, H. L. ,
Yang, C. T. ,
Zhao, J. H. ,
Huang, C. H. ,
Lin, H. Y. ,
Fang, H. W. ,
Ho, Y. &
Tsai, W. B. ,
9月 2007 ,
於: Biotechnology Progress. 23 ,
5 ,
p. 1231-1238 8 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
molecular dynamics
100%
Molecular Dynamics Simulation
87%
Zinc
75%
Ions
65%
zinc
62%